| Dr Thomas Bernard Edwards, MD | |
|
369 South St, Pittsfield, MA 01201-6803 | |
| (413) 443-4826 | |
| (413) 443-4488 |
| Full Name | Dr Thomas Bernard Edwards |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 41 Years |
| Location | 369 South St, Pittsfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740215771 | NPI | - | NPPES |
| 158837 | Other | MA | TUFTS HEALTH PLAN |
| 3178781 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 156926 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Berkshire Medical Center | Pittsfield, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Berkshire Allergy Care Pc | 3678865938 | 5 |
News Archive
Adolor Corporation today reported a net loss of $9.6 million, or $(0.21) per basic and diluted share, for the three months ended March 31, 2010, compared to a net loss of $13.2 million, or $(0.28) per basic and diluted share, for the three months ended March 31, 2009.
An immune-based therapy developed at Roswell Park Cancer Institute is moving forward with its third clinical trial. The early-stage clinical trial will assess whether SurVaxM — a cancer vaccine developed at Roswell Park — is a safe and effective treatment option for patients with multiple myeloma, a rare type of blood cancer.
The events of Sept. 11, 2001, changed the way Americans travel and view the world. They may also have made us sicker and more likely to access healthcare services, according to a new UC Irvine study.
A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.
› Verified 1 days ago
| Entity Name | Berkshire Allergy Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033328786 PECOS PAC ID: 3678865938 Enrollment ID: O20160706001651 |
News Archive
Adolor Corporation today reported a net loss of $9.6 million, or $(0.21) per basic and diluted share, for the three months ended March 31, 2010, compared to a net loss of $13.2 million, or $(0.28) per basic and diluted share, for the three months ended March 31, 2009.
An immune-based therapy developed at Roswell Park Cancer Institute is moving forward with its third clinical trial. The early-stage clinical trial will assess whether SurVaxM — a cancer vaccine developed at Roswell Park — is a safe and effective treatment option for patients with multiple myeloma, a rare type of blood cancer.
The events of Sept. 11, 2001, changed the way Americans travel and view the world. They may also have made us sicker and more likely to access healthcare services, according to a new UC Irvine study.
A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Bernard Edwards, MD 369 South St, Pittsfield, MA 01201-6803 Ph: (413) 443-4826 | Dr Thomas Bernard Edwards, MD 369 South St, Pittsfield, MA 01201-6803 Ph: (413) 443-4826 |
News Archive
Adolor Corporation today reported a net loss of $9.6 million, or $(0.21) per basic and diluted share, for the three months ended March 31, 2010, compared to a net loss of $13.2 million, or $(0.28) per basic and diluted share, for the three months ended March 31, 2009.
An immune-based therapy developed at Roswell Park Cancer Institute is moving forward with its third clinical trial. The early-stage clinical trial will assess whether SurVaxM — a cancer vaccine developed at Roswell Park — is a safe and effective treatment option for patients with multiple myeloma, a rare type of blood cancer.
The events of Sept. 11, 2001, changed the way Americans travel and view the world. They may also have made us sicker and more likely to access healthcare services, according to a new UC Irvine study.
A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.
› Verified 1 days ago